All COVID-19 articles – Page 3
-
NewsPHE updates COVID-19 chapter of the green book
Public Health England has issued updates to chapter 14a of the green book in line with new advice and evidence
-
News
JCVI issues autumn COVID-19 booster jab advice
UK vaccine adviser recommends a two-stage approach to coronavirus booster vaccine doses, beginning with those most at risk from serious disease
-
News
‘Strong immune response’ mixing AstraZeneca and Pfizer COVID-19 jabs
Research published in The Lancet suggests mixed vaccine schedules induce high concentrations of antibodies against SARS-CoV-2
-
News
PSNC reaches deal with UK Government on COVID-19 costs
The PSNC has accepted a revised offer from the UK Government for COVID-19-related cost claims on behalf of community pharmacies in England
-
News
Ivermectin to be investigated as possible treatment for COVID-19
The antiparasitic drug is being investigated in the UK as a possible treatment for COVID-19 in adults
-
News
NHS England pledges £30 million to improve the diagnosis and treatment of long COVID in primary care
GPs will receive a £30 million investment to establish a new enhanced service to support people with long COVID
-
NHS guideline
PHE maintaining immunisation programmes during COVID-19
A brief summary providing the key points for primary care on maintaining immunisation programmes during the COVID-19 pandemic
-
News
Pfizer COVID-19 vaccine approved in 12–15-year-olds
The Joint Committee on Vaccination and Immunisation will now advise on whether this age group will join the national COVID-19 vaccination programme
-
PHE/DH/DWP guideline
PHE inadvertent vaccination in pregnancy guideline
This concise and useful summary covers monitoring of women vaccinated in pregnancy or shortly before conception
-
News
One-dose Janssen COVID vaccine approved by MHRA
The vaccine is the first single-dose COVID-19 vaccine to be approved for use in the UK
-
NICE guideline
COVID-19 rapid guideline on gastrointestinal and liver conditions affecting immune response
A summary of guidance intended to maximise the safety of children and adults with gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic
-
NICE guideline
COVID-19 rapid guideline on dermatological conditions
The purpose of this Guidelines summary is to maximise the safety of children and adults who have dermatological conditions treated with drugs affecting the immune response during the COVID-19 pandemic
-
NICE guideline
COVID-19 guideline on rheumatological autoimmune, inflammatory, and metabolic bone disorders
This guideline aims to maximise the safety of children and adults with rheumatological autoimmune, inflammatory, and metabolic bone disorders during the COVID-19 pandemic
-
News
New advice on AstraZeneca COVID-19 vaccine issued following rare blood clot link
New advice has been issued by the MRHA and JCVI on the link between the COVID-19 AstraZeneca vaccine and thrombosis and thrombocytopenia
-
News
NICE publishes rapid guideline on managing COVID-19
NICE has published a new rapid guideline on the management of COVID-19, including recommendations for assessment, management, therapeutics and acute complications
-
PHE/DH/DWP guideline
PHE SARS-CoV-2 reinfection guideline
A concise summary of guidance on when to suspect SARS-CoV-2 reinfection and how to investigate and manage it in primary care
-
News
New guidance published on SARS-CoV-2 reinfection
The new recommendations from PHE aim to help clinicians identify and manage suspected cases of SARS-CoV-2 reinfection
-
News
New Psychological First Aid training course developed by PHE
The new online training course by PHE is available to those supporting children and young people affected by COVID-19
-
Independent professional body guideline
WHO COVID-19 clinical management guideline
An easy-to-digest summary of World Health Organization guidance for clinicians involved in the care of patients with suspected or confirmed COVID-19
-
NICE guideline
COVID-19 rapid guideline on systemic anticancer treatments
This summary aims to maximise the safety of patients with cancer and make the best use of NHS resources, while protecting staff from infection
